A Study of [14 C]-Pevonedistat in Participants With Advanced Solid Tumors
Clinical trial NCT03057366 · COMPLETED
Trial details
- NCT number
- NCT03057366
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-11
- Primary completion
- 2018-02-08
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.